{ "items": [ "\n\n
\n \n 20 July 2022\n \n
\n\n \n\n \n \n \nA large population-level assessment reveals third dose COVID-19 vaccination is effective for most patients with cancer, but effectiveness is lower than in the general population, particularly in patients who have undergone recent chemotherapy and those with lymphoma.
\n \n\n\n \n 6 July 2022\n \n
\n\n \n\n \n \n \nCongratulations to Ivan Ahel, Adrian Hill and Yang Shi on their election to the membership of the European Molecular Biology Organization (EMBO)
\n \n\n\n \n 28 June 2022\n \n
\n\n \n\n \n \n \nBody mass index, blood tests, comorbidities and medication use are temporally associated with cancer risk in the three years before a pancreatic cancer diagnosis.
\n \n\n\n \n 23 June 2022\n \n
\n\n \n\n \n \n \nNew, genetics and blood-based study links testosterone and insulin-like growth factor hormones to aggressive prostate cancer for the first time.
\n \n\n\n \n 25 May 2022\n \n
\n\n \n\n \n \n \nThe SELINA study will recruit patients with early liver cancers as part of the DeLIVER programme aiming to detect liver cancer earlier.
\n \n\n\n \n 24 May 2022\n \n
\n\n \n\n \n \n \nCOVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.
\n \n\n\n \n 17 May 2022\n \n
\n\n \n\n \n \n \nProfessor Julia Hippisley-Cox and Dr Tingting Zhu win funding for their collaborative project on novel test technologies for patient triage in primary care.
\n \n\n\n \n 6 May 2022\n \n
\n\n \n\n \n \n \nThe first major study to investigate dairy consumption and cancer risk in Chinese adults found that greater intake was associated with higher risks of liver cancer and female breast cancer.
\n \n\n\n \n 5 May 2022\n \n
\n\n \n\n \n \n \nA new Oxford study finds that greater body fat (adiposity) may increase the risk of dying from prostate cancer by up to 10%.
\n \n\n\n \n 4 May 2022\n \n
\n\n \n\n \n \n \nThe awardees from the 2021 round of the CRUK Oxford Centre Development fund have been announced. Read about what research they will be undertaking.
\n \n\n\n \n 3 May 2022\n \n
\n\n \n\n \n \n \nDr Daniel Hughes and colleagues identify NUDT15 as a potential biomarker for pancreatic cancer recurrence following surgery.
\n \n\n\n \n 28 April 2022\n \n
\n\n \n\n \n \n \nTesting for DPYD gene variants could be used to mitigate the side-effects of fluoropyrimidine-based chemotherapy
\n \n\n\n \n 8 April 2022\n \n
\n\n \n\n \n \n \nSeveral Oxford Cancer researchers present at the American Association for Cancer Research (AACR) Annual Meeting.
\n \n\n\n \n 6 April 2022\n \n
\n\n \n\n \n \n \nThe new Oxford-developed artificial intelligence tool PathProfiler automates the quality control of large retrospective pathology image datasets to increase their usability in downstream research.
\n \n\n\n \n 5 April 2022\n \n
\n\n \n\n \n \n \nOptellum Virtual Nodule Clinic, including its proprietary artificial intelligence lung cancer prediction solution, has achieved CE certification under the European Union\u2019s Medical Device Regulation.
\n \n\n\n \n 4 April 2022\n \n
\n\n \n\n \n \n \nProfessor Jason Davis has been awarded a Cancer Research UK Early Detection and Diagnosis Primer Award to develop a single-step, ultra-sensitive device for detecting breast cancer cells in the blood.
\n \n\n\n \n 15 March 2022\n \n
\n\n \n\n \n \n \nFaecal immunochemical testing (FIT) alone leads to the identification of the same number of patients with colorectal cancer as more complicated approaches that combine the FIT result with the results of commonly used blood tests.
\n \n\n\n \n 8 March 2022\n \n
\n\n \n\n \n \n \nNew data from the Million Women Study indicates that adiposity at different life stages is likely to affect the risk of postmenopausal breast cancer through distinct mechanisms.
\n \n\n\n \n 4 March 2022\n \n
\n\n \n\n \n \n \nA UK-first operation that replaced the sternum of a cancer patient using the chest wall of a deceased donor has been carried out at Oxford University Hospitals NHS Foundation Trust (OUH).
\n \n\n\n \n 24 February 2022\n \n
\n\n \n\n \n \n \nResults from a large-scale analysis show that following a vegetarian or pescatarian (fish-eating) diet could significantly reduce the risk of developing cancer \u2013 but even limiting red and processed meat to five meals a week or less may also have a benefit.
\n \n\n